In this single institution cross-sectional analysis of 589 chest CTA’s ordered for suspected PE, only 9% had a PE, 33% had other findings to explain the symptoms, and 24% had an incidental finding that required follow up (primarily a new nodule or new adenopathy). Given that almost a quarter of patients that receive a CTA for PE will have an incidental finding requiring follow-up, systematic procedures for ensuring this follow-up will be required (abstract).
Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.